Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasm Metastasis 1Melanoma 1Leukemia, Myelomonocytic, Chronic 1Kidney Neoplasms 1Carcinoma, Renal Cell 1

Interventions

aldesleukin 9Sunitinib 5Interferon-alpha 4Chemotherapy, Adjuvant 4pembrolizumab 3Vincristine 3Neoadjuvant Therapy 3Dactinomycin 3Cyclophosphamide 3Bevacizumab 3sargramostim 2fludarabine phosphate 2Robotic Surgical Procedures 2Radiotherapy 2Peripheral Blood Stem Cell Transplantation 2Laparoscopy 2Gene Expression Profiling 2Fluorouracil 2Etoposide 2Electroporation 2Doxorubicin 2Carboplatin 2Blood Specimen Collection 2Amplified Fragment Length Polymorphism Analysis 2tremelimumab 1toripalimab 1temsirolimus 1spartalizumab 1pazopanib 1orantinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Kidney Neoplasms × Histamine × Clear all
NCT00005038 2013-09-20

Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Metastatic Kidney Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡